EuBiologics Co., Ltd. (206650.KQ)
KRW 12130.0
(-3.58%)
KRW 12130.0
(-3.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 69.36 Billion | 55.46 Billion | 39.38 Billion | 28.48 Billion | 33.07 Billion | 24.89 Billion |
| Cost of Revenue | 36.7 Billion | 33.24 Billion | 25.12 Billion | 22.36 Billion | 14.32 Billion | 13.35 Billion |
| Gross Profit | 32.65 Billion | 22.22 Billion | 14.25 Billion | 6.12 Billion | 18.75 Billion | 11.53 Billion |
| Operating Expenses | 24.95 Billion | 25.99 Billion | 21.48 Billion | 12.08 Billion | 8.94 Billion | 6.22 Billion |
| Selling, General and Administrative Expenses | 3.43 Billion | 10.6 Billion | 5.74 Billion | 3.91 Billion | 4.85 Billion | 3.28 Billion |
| Research and Development Expenses | 17.88 Billion | 15.15 Billion | 15.64 Billion | 8.09 Billion | 3.95 Billion | 2.89 Billion |
| Other Expenses | 5 Billion | -223.54 Million | -99.43 Million | -80.67 Million | -136.38 Million | -45.36 Million |
| Cost and Expenses | 61.66 Billion | 59.23 Billion | 46.61 Billion | 34.45 Billion | 23.26 Billion | 19.57 Billion |
| Operating Income | 7.69 Billion | -3.76 Billion | -7.22 Billion | -5.96 Billion | 9.8 Billion | 5.31 Billion |
| Interest Expense | 1.05 Billion | 508.28 Million | 838.1 Million | 2.13 Billion | 324.93 Million | 46.11 Million |
| Income Tax Expense | 745.03 Million | 99.24 Million | -2.79 Billion | -460.78 Million | 253.5 Million | -2.48 Billion |
| Earnings before Tax | -14.61 Billion | -3.01 Billion | -30.69 Billion | -60.59 Billion | -628.12 Million | 1.29 Billion |
| Net Income | -13.87 Billion | -1.09 Billion | -27.57 Billion | -60.13 Billion | -881.62 Million | 3.78 Billion |
| Earnings Per Share Basic | -381.00 | -30.19 | -777.82 | -2146.27 | -32.35 | 145.87 |
| Earnings Per Share Diluted | -380.79 | -30.19 | -777.82 | -2146.27 | -32.35 | 145.87 |
| Weighted Average Shares Outstanding | 36.42 Million | 36.4 Million | 35.45 Million | 28.01 Million | 27.25 Million | 25.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.44 Million | 36.4 Million | 35.45 Million | 28.01 Million | 27.25 Million | 25.91 Million |
| Gross Margin | 0.47 | 0.40 | 0.36 | 0.21 | 0.57 | 0.46 |
| EBIT Margin | -0.06 | 0.07 | -0.02 | -0.00 | 0.39 | 0.29 |
| Profit Margin | -0.20 | -0.02 | -0.70 | -2.11 | -0.03 | 0.15 |
| EBITDA | -4.39 Billion | 5.37 Billion | -23.29 Billion | -52.5 Billion | 2.66 Billion | 3.3 Billion |
| Earnings Before Tax Margin | 0.11 | -0.07 | -0.18 | -0.21 | 0.30 | 0.21 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7.86 Billion | 15.18 Billion | 26.89 Billion | 69.36 Billion | 11.43 Billion | 16.64 Billion |
| Cost of Revenue | 3.88 Billion | 7.66 Billion | 13.44 Billion | 36.7 Billion | 8.11 Billion | 8.09 Billion |
| Gross Profit | 3.98 Billion | 7.52 Billion | 13.44 Billion | 32.65 Billion | 3.31 Billion | 8.55 Billion |
| Operating Expenses | 5.62 Billion | 5.14 Billion | 3.97 Billion | 24.95 Billion | 6.61 Billion | 6.56 Billion |
| Selling, General and Administrative Expenses | 1.61 Billion | 2.13 Billion | 2.34 Billion | - | 2.08 Billion | 601.66 Million |
| Research and Development Expenses | 3.98 Billion | 2.96 Billion | 1.59 Billion | - | 4.54 Billion | 5.92 Billion |
| Other Expenses | -33.14 Million | -46.2 Million | -42.78 Million | -108.87 Million | 4.96 Million | -36.38 Million |
| Cost and Expenses | 9.51 Billion | 12.81 Billion | 17.42 Billion | 61.66 Billion | 14.73 Billion | 14.65 Billion |
| Operating Income | -1.64 Billion | 2.37 Billion | 9.46 Billion | 7.69 Billion | -3.3 Billion | 1.99 Billion |
| Interest Expense | 344.01 Million | 262.67 Million | 289.64 Million | 1.05 Billion | 308.73 Million | 333.3 Million |
| Income Tax Expense | 9.57 Million | 2.97 Million | 745.03 Million | 745.03 Million | -320.29 Million | -477.56 Million |
| Earnings before Tax | -1.53 Billion | -3.61 Billion | -11.88 Billion | -14.1 Billion | -3.45 Billion | 1.63 Billion |
| Net Income | -1.59 Billion | -3.61 Billion | -12.7 Billion | -13.87 Billion | -3.1 Billion | 2.03 Billion |
| Earnings Per Share Basic | -43.59 | -99.17 | -348.63 | - | -85.10 | 55.92 |
| Earnings Per Share Diluted | -43.59 | -99.17 | -348.63 | - | -85.10 | 55.84 |
| Weighted Average Shares Outstanding | 36.48 Million | 36.45 Million | 36.45 Million | 36.44 Million | 36.44 Million | 36.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.48 Million | 36.45 Million | 36.45 Million | 36.44 Million | 36.44 Million | 36.49 Million |
| Gross Margin | 0.51 | 0.50 | 0.50 | 0.47 | 0.29 | 0.51 |
| EBIT Margin | 0.08 | 0.31 | 0.44 | - | -0.08 | 0.26 |
| Profit Margin | -0.20 | -0.24 | -0.47 | -0.20 | -0.27 | 0.12 |
| EBITDA | 650.47 Million | 4.66 Billion | 11.8 Billion | - | -949.32 Million | 4.32 Billion |
| Earnings Before Tax Margin | -0.21 | 0.16 | 0.35 | 0.11 | -0.29 | 0.12 |
BFAM
ZUO
NGI
KNG
603079
1438